Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?

Ahmet Omma; Duygu Tecer; Orhan Kucuksahin; Sevinc Can Sandikci; Fatih Yildiz; Sukran Erten

doi:10.5114/aoms.2017.70300

Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?

Arch Med Sci. 2018 Jun;14(4):830-837. doi: 10.5114/aoms.2017.70300. Epub 2017 Sep 26.

Authors

Ahmet Omma¹, Duygu Tecer², Orhan Kucuksahin³, Sevinc Can Sandikci¹, Fatih Yildiz⁴, Sukran Erten³

Affiliations

¹ Department of Rheumatology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
² Department of Rheumatology, Şanlıurfa Mehmet Akif İnan Training and Research Hospital, Şanlıurfa, Turkey.
³ Division of Rheumatology, Internal Medicine, Yildirim Beyazit University, Ankara, Turkey.
⁴ Department of Rheumatology, Van Training and Research Hospital, Van, Turkey.

Abstract

Introduction: The aim of the study was to investigate whether there is a relationship between the European League Against Rheumatism (EULAR) outcome measures and quality of life (QoL), fatigue, anxiety and depression in patients with pSS and to define determinants which could affect quality of life.

Material and methods: The study included 105 pSS patients and 72 age/sex-matched healthy controls (HCs). Cross-sectional clinical data were collected, including the Hospital Anxiety and Depression Scale (HADS), the Multidimensional Assessment of Fatigue (MAF) scale, the Short Form (SF-36), EULAR Sjögren's syndrome disease activity index (ESSDAI) and EULAR Sjögren's syndrome patient reported index (ESSPRI).

Results: The SF-36 scores were significantly lower and anxiety, depression and fatigue scores were significantly higher in the pSS group than in the control group (all p-value < 0.05). ESSDAI was negatively correlated with SF-36 scores and positively with MAF. ESSPRI was negatively correlated with SF-36 scores except for the mental health subdimension, and a positive correlation was determined with MAF, HADS-A and HADS-D. Multiple linear regression analysis revealed that HADS-A, HADS-D, MAF, ESSPRI and ESSDAI were associated with most SF-36 subscales.

Conclusions: The results of this study provide further evidence supporting the use of ESSDAI and ESSPRI in daily practice. Quality of life was diminished in patients with pSS and was associated with different symptoms. This should be taken into account when managing patients with pSS.

Keywords: EULAR Sjögren’s syndrome disease activity index; EULAR Sjögren’s syndrome patient reported index; Sjögren’s syndrome; anxiety; depression; quality of life.